Monday Items for #BIO2012 Business Forum

Posted under 2012 BIO International Convention, 2012 Business Forum, BIO Business Forum, Blog, Business and Investments, Companies, Diagnostics, Funding, how-to's & tutorials, Medical Devices, Medical Supply, One-on-One's, Partnering, Pharmaceuticals, profile, scheduling, Startups, Universities, Videos, webinar, What would George do? by biotechnow@bio.org (Biotechnology Industry Organization)

Happy Monday Everyone! We thought we would do a quick post on some important items concerning the BIO Business Forum and One-on-One Partnering.

• The Profile Publication Deadline is May 22nd.

Why is this important? For one, if you have not published your profile, companies just have a harder time finding you. Make it easy for them. Fill out your keywords; provide as much detail in the assets/products/services categories as possible; Publish and Save! Second, publishing by May 22nd ensures that your profile will be included in the flash drives to be distributed at the event.

Don’t know how to publish your profile? Watch the video (under 1 minute).

• Scheduling will begin the week of May 28th.

Stay tuned for our post on how this process works. But for now, what this means for you is you should send your meeting requests, and accept the meetings you want to attend. Why? Because once the scheduler starts, people’s calendars will fill up FAST.

• Partnering Town Hall Meeting is coming!

This webinar will be Tuesday, May 22nd from 11:30 am – 12:30 pm EDT. We’re going to be taking your questions, on everything and anything you want to know.

• Status Update: We’re officially over the 18,000 mark of meeting requests in the system. As of today, there are 2,340 companies in the system, ahead of where we were this time last year, and close to 2,000 meetings already in the queue to be scheduled.

That’s it for this Monday. If there’s anything specific you’d like to learn more about, or feel would just be a good post, let us know. Happy Partnering!

Announcing the Buzz of BIO Winner for Pipelines of Promise!

Posted under 2012 BIO International Convention, 2012 Business Forum, BIO Business Forum, Blog, Business and Investments, Buzz of BIO, Companies, contest, Diagnostics, Events, Funding, Medical Devices, Medical Supply, One-on-One's, Partnering, Pharmaceuticals, Startups, Universities, Videos, What would George do? by biotechnow@bio.org (Biotechnology Industry Organization)

We’re very pleased to announce the Buzz of BIO Winner for the 2012 contest of the BIO International Convention. You voted for your favorites, and it was a tight, interesting race! As such, we’re pleased to introduce you to our winner for the Pipelines of Promise category.

Deuteria Pharmaceuticals, Inc,. who focuses on improving the product profile of approved drugs through ‘chiral switching’, won the Pipelines of Promise category. From Dr. Sheila DeWitt, the company’s president, “As an emerging company with a pioneering approach to therapeutics, Deuteria Pharmaceuticals is pleased to be recognized as a Pipeline of Promise company by the premier conference in the biotechnology industry. This recognition from BIO 2012 provides and strengthens the visibility of Deuteria Pharmaceuticals.” View their website here.

You’ll definitely be seeing these folks around the International Convention. Be sure to look for them in the One-on-One Partnering System, plus, they’ll be giving a presentation in the BIO Business Forum.

Thanks to everyone who participated!

myBIO and One-on-One Partnering… What’s the Difference?

Posted under 2012 BIO International Convention, 2012 Business Forum, Blog, Companies, Diagnostics, Funding, Medical Devices, Medical Supply, myBio, One-on-One's, Partnering, Pharmaceuticals, profile, Startups, Universities, Videos, What would George do? by biotechnow@bio.org (Biotechnology Industry Organization)

This June, thousands will gather in the biotech hub of Boston!

One of the things the team has been hard at work on, is the online community of myBIO, as those who have attended the Convention in the past will recognize. It’s a very handy, interactive tool that allows you to track companies, communicate with other attendees, and get a bird’s-eye view of all the different events going on. As a registrant, you even have your own profile that can include your photo, your company’s website, and your own social media accounts, like LinkedIn and Twitter feeds.

For those who are completely new to the event, we thought we could dig in to some of the differences between myBIO, and what BIO One-on-One Partnering™ is. Here’s a brief run-down of some topics, the details of which will be discussed further into the post.

Now let’s go into this in more depth.

Number 1:  What’s the difference between a personal event planner, and a meeting scheduler anyway? Essentially, you should use myBIO to plan your day around the events at the BIO Convention, such as the breakout sessions, keynotes, happy hours and so on. Think of it as Google Calendar, with a little Buzz thrown in. myBIO is not the platform that’s used to schedule private meetings with other companies and attendees. After all, the One-on-One Partnering System is all about that: Partnering. So One-on-One Partnering is what you use to send meeting requests to companies you otherwise wouldn’t have access to, and where you can let others know about your products or exciting additions to your pipeline.

Number 2:  How do I know if I have access to myBIO or BIO One-on-One Partnering? Will I know the difference? Yes, you will! If you’re coming to the BIO International Convention, you’re automatically given a myBIO account. It’s just a part of the registration process. In fact, profile details are taken directly from the information you provide during registration, so you don’t need to sign up for it.

One-on-One Partnering on the other hand, because it provides exclusive access to companies, is a separate designation when Registering. If you’re interested in the Business Forum, you must choose either the “Full Convention Access & Partnering” or the “Convention Access & Partnering” Registration Packages. Or if you’re an exhibitor, you would have received information regarding Partnering when registering your booth personnel. Another way to know: if you have it, we’ll send you login info for it, plus details, and step-by-step instructions on how to use Partnering effectively and successfully.

Number 3:  Okay, let’s say I’m signed up for both. Then how do I get to myBIO? And how do I get to One-on-One Partnering? myBIO is always accessible through the main Convention website, at convention.bio.org/mybio

To access BIO One-on-One Partnering, just visit the link in the email that contains your login credentials or go to: oneononepartnering.bio.org/BusinessForum2012. Plus, there are multiple ways to log in from the Convention website that will take you to this page, too.

Everything about Partnering is contained within the One-on-One site. So if you want to send a meeting request, if you want to see your calendar of meetings, when and where — the One-on-One Partnering System is your one-stop shop. You can also add notes to your delegate meeting calendar.

Number 4:  Tell me more about the differences between these two profiles. Think of it this way: the One-on-One Partnering System provides a detailed overview of all the participating companies and who and what they are, while myBIO is more of a look at the individuals within those companies and the events their participating in.

Those who are Partnering at the event will also receive emails from us, reminding you to publish your profile before our deadlines. It’s an easy process, but actually clicking the Publish and Save buttons on the site is important.

This allows your company to be fully visible and searchable in the Partnering System, which also tends to get companies more meetings. And if you’re ever unsure about which profile needs updating, you can always just follow the link we provide you in these emails.

Questions? Comments? Let us know!

Industry Regulatory Issues to be Highlighted at 2012 BIO International Convention

Posted under 2012 BIO International Convention, biosimilars, biotech regulation, Blog, Companies, Diagnostics, Events, FDA, Food and Drug Administration, Funding, Medical Devices, Medical Supply, PDUFA, Pharmaceuticals, regulation, Startups, Universities, Videos by biotechnow@bio.org (Biotechnology Industry Organization)

In the words of BIO’s Andrew Emmett, Managing Director, Science & Regulatory Affairs, ‘2012 is shaping up to be a momentous year for FDA reform.’ From the reauthorization of the Prescription Drug User Fee Act (PDUFA V) to modernizing and expediting the approval of new drugs and biologics, implementing the new biosimilars pathways and addressing the growing global drug shortage crisis, all eyes are on the current regulatory environment and its role in supporting innovation.

The 2012 BIO International Convention will return to Boston, MA and the Boston Convention and Exhibition Center, June 18-21, 2012 and will feature a breakout session track on regulatory issues.

Attendees can expect the Achieving Regulatory Approval and Compliance educational track to feature leading Food & Drug Administration (FDA) leaders who will share their prospective priorities, senior European medical agency executives discussing international and harmonization issues as well as major biotechnology and pharmaceutical companies exploring best practices and addressing questions.

With drug development a long and costly process, speakers will also address how companies can continue to innovate and attract investor capital.

Highlights include:

FDA Town Hall

Tuesday, June 19, 2:00 p.m. – 3:30 p.m.

Speakers: Karen Midthun, MD, Director, Center for Biologics Evaluation and Research, Food and Drug Administration (FDA) and Janet Woodcock, Center for Drug Evaluation and Research, Food and Drug Administration (FDA)

PDUFA V: Impact on Innovation, Patients, and Modern Medicines – Super Session

Wednesday, June 20, 3:30 p.m. – 5:15 p.m.

Moderator: Steve Usdin, Washington Editor, BioCentury, Co-host, BioCentury This Week

Speakers: Marc Boutin, JD, Executive Vice President and Chief Operating Officer, National Health Council, Peter Greenleaf, President, MedImmune, and Margaret Hamburg, M.D., Commissioner of Food and Drug Administration (FDA)

Analysis and Impact of PDUFA V: What Regulatory Affairs Professionals Need to Know

Tuesday, June 19, 8:30 a.m. – 9:45 a.m.

Moderator:  Janet Jenkins-Showalter, Senior Regulatory Group Director, Genzyme, A Member of the Roche Group

Speakers:  Andrew Emmett, Managing Director, Science and Regulatory Affairs, Biotechnology Industry Organization, Kay Holcombe, Senior Policy Advisor, Genzyme, a Sanofi Company, and Patrick Frey, Director, Office of Planning and Analysis, Center for Drug Evaluation and Research (CDER), Food and Drug Administration

Interchangeable Biosimilars: Distinguishing between Aspiration and Achievement

Thursday, June 21, 8:30 a.m. – 9:45 a.m.

Moderator:  Ramsey Baghdadi, Senior Editor, The RPM Report

Speakers: Erika Lietzan, Special Counsel, Covington & Burling LLP, Joseph Miletich, Senior Vice President, Research and Development, Amgen, Gregory Schimizzi, Co-Founder, Carolina Arthritis, Coalition of State Rheumatology Organizations and Jan Wyatt, Patient Advocate, Arthritis Foundation

Biological Product Pediatric Development in the US: Implementation of PREA and BPCIA

Monday, June 18, 3:45 p.m. – 5:00 p.m.

Moderator: Chin Koerner, Executive Director, Novartis Pharmaceuticals

Speakers: Barbara Buch, MD, Supervisory Medical Officer, Center for Biologics and Evaluation Research, Food and Drug Administration (FDA), Sharon Olmstead, Vice President, Novartis Pharmaceuticals and Karen Weiss, Vice President, Janssen Research and Development

To learn more about the Achieving Regulatory Approval and Compliance educational track and get the most up-to-date program and speaker information, visit http://convention.bio.org/program/.